同伴小组问题管理plus(PM+)对土耳其成年叙利亚难民随机对照试验方案
本研究为随机对照试验方案,拟在土耳其招募380名高心理困扰且功能受损的成年叙利亚难民,随机分配至同伴小组PM+/强化常规照护组或强化常规照护组,评估心理健康结局与成本效果。
要点
- 同伴小组PM+由非专业同伴在社区实施,针对高心理困扰和功能受损的难民。
- 主要结局为HSCL-25测量的心理困扰,随访至基线后12个月。
- 将评估干预的成本效益,并开展过程评价探索可行性。
核心结论
- 方案旨在评估同伴小组PM+/E-CAU相比E-CAU对叙利亚难民心理困扰和功能受损的效果与成本效益。
研究设计与样本
- 随机对照试验,计划纳入380名土耳其成年叙利亚难民,随机分为Group PM+/E-CAU组(n=190)和E-CAU组(n=190)。
- 纳入标准:K10评分>15且WHODAS 2.0评分>16。
- 结局评估在第五次会话后1周、第五次会话后3个月和基线后12个月进行。
关键数值与推荐
- 主要结局为HSCL-25测量的心理困扰;次要结局包括功能受损、创伤后应激症状、自认问题和卫生系统与生产力成本。
- 过程评价将纳入25名参与者(包括参与者、引导者、政策制定者和心理健康专业人员)。
临床怎么用
- 若证实有效且成本效益良好,WHO将提供叙利亚阿拉伯语小组PM+治疗手册和培训材料,供非专业同伴在社区实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A large proportion of Syrians have been exposed to potentially traumatic events, multiple losses, and breakdown of supportive social networks and many of them have sought refuge in host countries where they also face post-migration living difficulties such as discrimination or integration problems or both. These adversities may put Syrian refugees at high risk for common mental disorders. In response to this, the World Health Organization (WHO) developed a trans-diagnostic scalable psychological intervention called Problem Management Plus (PM+) to reduce psychological distress among populations exposed to adversities. PM+ has been adapted for Syrian refugees and can be delivered by non-specialist peer lay persons in the community. METHODS: A randomized controlled trial (RCT) will be conducted with 380 Syrian refugees in Turkey. After providing informed consent, participants with high levels of psychological distress (scoring above 15 on the Kessler-10 Psychological Distress Scale (K10)) and functional impairment (scoring above 16 on the WHO Disability Assessment Schedule 2.0, or WHODAS 2.0) will be randomly assigned to Group PM+/enhanced care as usual (Group PM+/E-CAU) (n = 190) or E-CAU (n = 190). Outcome assessments will take place 1 week after the fifth session (post-assessment), 3 months after the fifth session and 12 months after baseline assessment. The primary outcome is psychological distress as measured by the Hopkins Symptom Checklist (HSCL-25). Secondary outcomes include functional impairment, post-traumatic stress symptoms, self-identified problems, and health system and productivity costs. A process evaluation will be conducted to explore the feasibility, challenges and success of the intervention with 25 participants, including participants, facilitators, policy makers and mental health professionals. DISCUSSION: The treatment manual of the Syrian-Arabic Group PM+ and training materials will be made available through the WHO once the effectiveness and cost-effectiveness of Group PM+ have been established. TRIAL REGISTRATION: Clinical Trial Registration: ClinicalTrials.gov Identifier NCT03960892. Unique protocol ID: 10/2017. Prospectively registered on 21 May 2019.
引用
- Uygun E, Ilkkursun Z, Sijbrandij M, et al. Protocol for a randomized controlled trial: peer-to-peer Group Problem Management Plus (PM+) for adult Syrian refugees in Turkey. Trials. 2020. PMID: 32192539. doi:10.1186/s13063-020-4166-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。